Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference
11 mars 2024 08h00 HE
|
Nitrase Therapeutics
-Nitrase’s first-in-class antibody found to significantly delay progression of Parkinson’s disease in preclinical models by blocking the propagation of pathogenic nitrated synuclein-Advancing...
Nitrase Therapeutics Announces Presentation at the SFN Neuroscience 2023 Annual Meeting
02 nov. 2023 16h00 HE
|
Nitrase Therapeutics
BRISBANE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new...
Nitrase Therapeutics Announces Publication in the Journal of Biological Chemistry on the Role of Tyrosine Nitration in Cell Signaling and Cancer Biology
13 juil. 2023 08h00 HE
|
Nitrase Therapeutics
BRISBANE, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new...
Nitrase Therapeutics Presents Preclinical Data on the Role of Enzymatic Nitration in Oncology at the American Association for Cancer Research Annual Meeting
18 avr. 2023 16h00 HE
|
Nitrase Therapeutics
BRISBANE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new...
Nitrase Therapeutics Presented New Findings on the Role of Synuclein Nitrase in Alpha Synuclein Nitration and Aggregation, as well as Motor Dysfunction at the 2023 Alzheimer's & Parkinson's Diseases (AD/PD) Conference
28 mars 2023 08h00 HE
|
Nitrase Therapeutics
BRISBANE, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new...
Nitrase Therapeutics to Present at the 2023 American Association for Cancer Research Annual Meeting
14 mars 2023 16h30 HE
|
Nitrase Therapeutics
BRISBANE, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new...
Nitrase Therapeutics Presented Data on the Importance of Synuclein Nitrase on the Synaptic Activity of Differentiated Dopaminergic Neurons at the Society for Neuroscience (SFN) Conference
14 nov. 2022 08h00 HE
|
Nitrase Therapeutics
-Data Elucidate Role of Company-identified Enzyme, Synuclein Nitrase, in Parkinson’s Disease- BRISBANE, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical...
Nitrase Therapeutics Presented Data on Role of Novel Nitrases in Regulating Known and Important Cancer Targets at EORTC-NCI-AACR Symposium
31 oct. 2022 08h00 HE
|
Nitrase Therapeutics
BRISBANE, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new...
Nitrase Therapeutics Appoints Arun Kashyap, Ph.D., to Lead its Recently Launched Oncology Programs as Senior Vice President of Oncology
07 sept. 2022 08h00 HE
|
Nitrase Therapeutics
BRISBANE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new...
Nitrase Therapeutics Expands Leadership Team with Accomplished Drug Discovery and Development Executives
06 juil. 2022 08h00 HE
|
Nitrase Therapeutics
SAN FRANCISCO, July 06, 2022 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new...